First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safety
Takafumi Yanagisawa(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine), Tatsushi Kawada(Okayama University), Wataru Fukuokaya(Jikei University School of Medicine), Takeshi Hashimoto(Tokyo Medical University), Satoshi Katayama(Okayama University), Haruhito Azuma(Osaka University of Pharmaceutical Sciences), Kazuki Nishimura(Osaka University of Pharmaceutical Sciences), Masaya Murakami(Jikei University School of Medicine), Takuhisa Nukaya(Fujita Health University), Kiyoshi Takahara(Osaka Medical and Pharmaceutical University), Shingo Toyoda(Kindai University), Yoshio Ohno(Tokyo Medical University), Tomoaki Yamanoi(Okayama University), Motoo Araki(Okayama University), Kazumasa Komura(Kawasaki Medical School), Kazutoshi Fujita(Kindai University), Ryoichi Shiroki(Fujita Health University), Kensuke Bekku(Okayama University), Taizo Uchimoto(Osaka University of Pharmaceutical Sciences), Hirotsugu Uemura(Kindai University), Keiichiro Mori(Jikei University School of Medicine), Takahiro Adachi(Tokyo Medical University), Takuya Tsujino(Osaka University of Pharmaceutical Sciences)
Cited by 7
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
|eLife|2018|191
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
|Proceedings of the National Academy of Sciences|1996|167
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129